Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 489
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +27.7%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 251–300 of 1,382 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06710756	Lead-212 PSV359 Therapy for Patients With Solid Tumors	recruiting	Phase 1 / Phase 2	112	Perspective TherapeuticsINDUSTRY	1	Jul 6, 2026	clinicaltrials
NCT07683845	Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer	recruiting	—	164	Beijing Daxiang Biotech Co., LtdINDUSTRY	1	Jul 6, 2026	clinicaltrials